Fig. 1From: Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcomaThe landscape of tumor-infiltrating immune cells in osteosarcoma. a. The proportion of 22 immune cell types in osteosarcoma tissues. b. Correlation matrix between 22 immune cell types in osteosarcomaBack to article page